Board of Directors
Min Yang - Chair
Min Yang, the Chair of BSF Enterprise, possesses a wealth of experience spanning over 30 years of in international investment. Min’s expertise lies in the identification, acceleration and realisation of investments across a range of industries including property, resources, technology and finance.
Geoff Baker - Director
Geoff, the Director of BSF Enterprise, is a qualified lawyer in Australia and Hong Kong. He holds a commerce degree, law degree and a Master of Business Administration. Geoff has practiced extensively for 30 years as a lawyer in Australia, Japan, across Asia and China.
Dr. Che Connon - Managing Director
Dr. Che Connon, the Managing Director of BSF Enterprise, has over 20 years of experience in extracellular matrix biology. He is currently a Professor of Tissue Engineering at Newcastle University. Dr. Connon has successfully spun out 3 biotech companies.
Dennis Ow - Non-Executive Director
Dennis Ow, the Non-Executive Director of BSF Enterprise, was a business development and corporate finance executive at various investment banks in Asia. Dennis served as the former Asia Pacific Senior Business Manager for the London Stock Exchange.
Graham Duncan - CFO
Graham Duncan, the Chief Financial Officer of BSF Enterprise, is a Chartered Accountant with over 20 years of capital markets experience. He holds a Corporate Finance Diploma issued by the ICAEW and has specialised in advising UK-listed companies.
The Directors acknowledge the importance of high standards of corporate governance and intend, given the Company’s size and the constitution of the Board, to comply with the principles set out in the QCA Code. The QCA Code sets out a standard of minimum best practice for small and mid-size quoted companies.
Upon Admission, the Board will comprise four Directors, one of whom one will be an Executive Director and the remaining three Non-Executive Directors, reflecting a blend of different experiences and backgrounds.
The QCA Code states that a company should have at least two independent non-executive directors. At Admission the Company will only have one independent non-executive directors being Mr Dennis Ow. The Board believes that the composition of the Board brings a desirable range of skills and experience in light of the Company’s challenges and opportunities following Admission, while at the same time ensuring that no individual (or a small group of individuals) can dominate the Board’s decision making. The Company will appraise the structure of the Board on an ongoing basis.
The Board intends to meet regularly to review, formulate and approve the Enlarged Group’s strategy, budgets, and corporate actions and oversee the Enlarged Group’s progress towards its goals.
The Company has established an Audit Committee, a Remuneration Committee and a Nomination Committee, each with formally delegated duties and responsibilities and with written terms of reference. The Company will review its compliance with the recommendations of the QCA Code and, following Admission, report in its annual report and accounts and on its website where it complies and explain where it does not comply
Geoffrey Robert Baker
Auditors to the Company
PKF Littlejohn LLP
5 Westferry Circus
London, E14 4HD
Solicitors to the Company as to English Law
Locke Lord (UK) LLP
London EC2M 3AB
Share Registrars Limited
The Courtyard, 17 West Street
Surrey GU9 7DR
Reporting Accountants to the Company
Crowe U.K. LLP
55 Ludgate Hill
London EC4M 7JW
Placing Agent and Advisor
Shard Capital Partners LLP
23rd Floor, 20 Fenchurch St,
London EC3M 3BY
Solicitors to the Sellers
100 Old Hall Street
Liverpool L3 9QJ
SEC Newgate (UK)
14 Greville Street
London EC1N 8SB